SCHEMBL5470543

SCHEMBL5470543

Cc1nc(N)nc2c1C(=O)CC(c1ccccc1OC(C)C)C2

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 9/20 0.62
HSP90AB1 P08238 8/20 0.62
GPBAR1 Q8TDU6 1/20 0.40
HPGD P15428 3/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TSHR P16473 1/20 0.40
HDAC4 P56524 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.38
TRAP1 Q12931 1/20 0.38
TP53 P04637 1/20 0.36
MAP1LC3B Q9GZQ8 1/20 0.36
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779006 0.87 HSP90AA1 (0.66) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5457745 0.87 HSP90AA1 (0.52) HSP90AA1HSP90AB1HPGDTRAP1
SCHEMBL5471332 0.84 HSP90AA1 (0.62) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5463191 0.84 HSP90AA1 (0.62) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL4620866 0.84 HSP90AA1 (0.65) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5470114 0.84 HSP90AA1 (0.56) HSP90AA1HSP90AB1GPBAR1HPGDALDH1A1
SCHEMBL14582379 0.83 HSP90AA1 (0.60) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5465114 0.83 HSP90AA1 (0.60) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL5459772 0.83 HSP90AA1 (0.60) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2
SCHEMBL4618394 0.83 HSP90AA1 (0.60) HSP90AA1HSP90AB1HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885GPBAR1 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.